---
title: "Verzenio (abemaciclib), all indications: Indication questions"
description: "Indication questions on Verzenio (abemaciclib) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: What is the generic name of Verzenio? Who makes Verzenio? When was Verzenio first approved by the FDA? 3 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/verzenio/indication"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Verzenio (abemaciclib), all indications: Indication questions

Manufacturer: Lilly USA, LLC  
Prescribing information: [Verzenio](https://uspl.lilly.com/verzenio/verzenio.html#pi)  
Indication pages: [HR-positive HER2-negative early breast cancer](https://www.evicenter.com/medical-information/verzenio--hr-positive-her2-negative-early-breast-cancer)

## Drug names

<a id="verzenio-generic-name"></a>

### What is the generic name of Verzenio?

> “VERZENIO® (abemaciclib) tablets, for oral use”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=VERZENIO%C2%AE%20%28abemaciclib%29%20tablets%2C%20for%20oral%20use)

> “Abemaciclib is a kinase inhibitor for oral administration.”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=Abemaciclib%20is%20a%20kinase%20inhibitor%20for%20oral%20administration.)

<a id="verzenio-manufacturer"></a>

### Who makes Verzenio?

> “Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, USA”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=Marketed%20by%3A%20Lilly%20USA%2C%20LLC%2C%20Indianapolis%2C%20IN%2046285%2C%20USA)

## Indication

<a id="verzenio-approval-year"></a>

### When was Verzenio first approved by the FDA?

> “VERZENIO® (abemaciclib) tablets, for oral use
> Initial U.S. Approval: 2017”

Source: [VERZENIO: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/verzenio/verzenio.html#pi:~:text=VERZENIO%C2%AE%20%28abemaciclib%29%20tablets%2C%20for%20oral,Initial%20U.S.%20Approval%3A%202017)

## Related pages
- [Medical information: Verzenio (abemaciclib): All indications](https://www.evicenter.com/medical-information/verzenio)
- [Pharmacology](https://www.evicenter.com/medical-information/verzenio/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/verzenio/safety)
- [Specific populations](https://www.evicenter.com/medical-information/verzenio/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/verzenio/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/verzenio/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/verzenio/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/verzenio/access-and-coverage)
